The estimated Net Worth of Hermann Fritz Requardt is at least $2.63 Million dollars as of 4 March 2024. Hermann Requardt owns over 15,000 units of Bruker Corp stock worth over $2,441,027 and over the last 9 years he sold BRKR stock worth over $0. In addition, he makes $193,012 as Independent Director at Bruker Corp.
Sign up
Hermann Requardt BRKR stock SEC Form 4 insiders trading
Hermann has made over 1 trades of the Bruker Corp stock since 2024, according to the Form 4 filled with the SEC. Most recently he exercised 15,000 units of BRKR stock worth $330,750 on 4 March 2024.
The largest trade he's ever made was exercising 15,000 units of Bruker Corp stock on 4 March 2024 worth over $330,750. On average, Hermann trades about 1,364 units every 0 days since 2015. As of 4 March 2024 he still owns at least 38,147 units of Bruker Corp stock.
You can see the complete history of Hermann Requardt stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Hermann Requardt biography
Dr. Hermann Fritz Requardt serves as Independent Director of the Company. Dr. Requardt currently serves as an independent strategic advisor to a number of European public and private life science and healthcare technology companies. From 2009 to February 2015 he served as Chief Executive Officer of the healthcare division of Munich, Germany-based Siemens AG. He also served as Chief Technology Officer of Siemens AG from 2008 through 2011. Additionally, from 2006 through January 2015, he was a member of the Siemens AG Managing Board, during which time he also held a variety of regional and operational responsibilities at Siemens AG and its affiliates. Dr. Requardt joined Siemens AG Medical Solutions in 1984 and served there in roles of increasing responsibility before assuming global responsibility for the magnetic resonance business unit in 1994. Dr. Requardt is an honorary Professor of Physics at the University of Frankfurt and serves on several academic and industrial boards in Germany, including, among other positions, Vice President of Acatech, the National Academy of Science and Engineering. He also is a member of the Advisory Board of Dekra SE, headquartered in Stuttgart, Germany, and the Supervisory Board of Sivantos Group, which was Siemens Audiology Solutions prior to its spin-off from Siemens AG in early 2015. In 2018, Dr. Requardt was nominated as non-executive director of Sphere Medical Ltd., Cambridge, United Kingdom. Dr. Requardt holds a Ph.D. in Biophysics, with a focus on radiation biophysics and microbiology, from the University of Frankfurt.
What is the salary of Hermann Requardt?
As the Independent Director of Bruker Corp, the total compensation of Hermann Requardt at Bruker Corp is $193,012. There are 17 executives at Bruker Corp getting paid more, with Frank Laukien having the highest compensation of $4,909,640.
How old is Hermann Requardt?
Hermann Requardt is 65, he's been the Independent Director of Bruker Corp since 2015. There are 3 older and 17 younger executives at Bruker Corp. The oldest executive at Bruker Corp is Marc Kastner, 74, who is the Independent Director.
What's Hermann Requardt's mailing address?
Hermann's mailing address filed with the SEC is BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA, MA, 01821.
Insiders trading at Bruker Corp
Over the last 21 years, insiders at Bruker Corp have traded over $527,877,336 worth of Bruker Corp stock and bought 5,273,190 units worth $50,472,973 . The most active insiders traders include Joerg C Laukien, Isolde Laukien, and Marc M Laukien. On average, Bruker Corp executives and independent directors trade stock every 36 days with the average trade being worth of $16,426,809. The most recent stock trade was executed by Bob Rosenthal on 15 August 2024, trading 12,500 units of BRKR stock currently worth $292,125.
What does Bruker Corp do?
right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www
What does Bruker Corp's logo look like?
Complete history of Hermann Requardt stock trades at Bruker Corp
Bruker Corp executives and stock owners
Bruker Corp executives and other stock owners filed with the SEC include:
-
Frank Laukien,
Chairman of the Board, President, Chief Executive Officer -
Mark Munch,
Executive Vice President, President of Bruker Nano Group and Bruker Nano Surfaces Division -
Juergen Srega,
President of Bruker CALID Group and Bruker Daltonics Division -
Gerald Herman,
Chief Financial Officer -
Dr. Frank H. Laukien Ph.D.,
Chairman, CEO & Pres -
Burkhard Prause,
President and Chief Executive Officer, Bruker Energy & Supercon Technologies, Inc -
Falko Busse,
President, Bruker BioSpin Group -
Dr. Mark R. Munch Ph.D.,
Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division -
Juergen Srega,
Pres of Bruker CALID Group & Bruker Daltonics Division -
Gerald N. Herman,
Exec. VP, CFO, Corp. Controller & Interim Head of IR -
Dr. Falko Busse Ph.D.,
Pres of Bruker BioSpin Group -
John Ornell,
Independent Director -
Richard Packer,
Independent Director -
Robert Rosenthal,
Independent Director -
Adelene Perkins,
Independent Director -
William Linton,
Lead Independent Director -
Marc Kastner,
Independent Director -
Hermann Requardt,
Independent Director -
Cynthia Friend,
Independent Director -
Miroslava Minkova,
Director, Investor Relations & Corporate Development -
Bonnie Anderson,
Independent Director -
J. Brent Alldredge J.D.,
Gen. Counsel -
Justin Joseph Ward,
Sr. Director of Investor Relations & Corp. Devel. -
Kristin S. Caplice,
Sec. -
Dr. Burkhard Prause,
Pres and CEO of Bruker Energy & Supercon Technologies, Inc. -
Urban Faeh,
Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH -
Stacey Desrochers,
Treasurer & Director of Investor Relations -
Collin J. D'Silva,
Pres of Chemical Analysis Division -
M Christopher Canavan,
Director -
Richard Kniss,
Director -
Ingen Chris Van,
Director -
Stephen W. Fesik,
Director -
Rene Lenggenhager,
President, BioSpin Group -
Anthony L Mattacchione,
Sr VP, Corp Fin & Accounting -
Gilles Gerard Jean Martin,
Director -
Joerg C Laukien,
10% owner -
Michael Gunnar Knell,
Chief Accounting Officer -
Brenda J Furlong,
Director -
Wolf Dieter Emmerich,
Director -
Taylor Crouch,
Director -
Bob Rosenthal,
-
Laura Francis,
Chief Financial Officer -
John Hulburt,
Dir. of Audit /SEC Compliance -
Martin Haase,
Senior Vice President -
Thomas Werner Bachmann,
President Bruker BioSpin Group -
Charles F Jr Wagner,
Director -
Bernhard Wangler,
Director -
Bernd Gewiese,
President, Bruker BioSpin Corp -
Werner Maas,
President, Bruker BioSpin Corp -
Tony Werner Keller,
Director -
Brian P Monahan,
Corporate Controller -
Dirk D Laukien,
10% owner -
Marc M Laukien,
10% owner -
William J Knight,
Chief Financial Officer -
Richard M Stein,
Secretary -
Isolde Laukien,
10% owner -
Collin J Dsilva,
Director -
Philip Ma,